InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Renee PremiumMember
10/12/22 4:39 PM
profile icon
DFRANK1970 Free
01/06/14 4:11 PM
profile icon
juxtaposezen Free
12/18/12 2:11 PM
profile icon
juxtaposezen Free
12/17/12 3:29 PM
profile icon
juxtaposezen Free
12/17/12 11:46 AM
profile icon
biocqr PremiumMember
11/13/12 8:45 AM
profile icon
biocqr PremiumMember
11/11/12 2:24 PM
profile icon
biocqr PremiumMember
11/07/12 11:35 AM
profile icon
biocqr PremiumMember
11/06/12 8:50 PM
profile icon
biocqr PremiumMember
11/06/12 6:49 PM
profile icon
biocqr PremiumMember
10/11/12 5:35 PM
profile icon
serafin1982 Free
08/12/12 8:51 PM

Allon Therapeutics (fka NPCUF) RSS Feed

Followers
2
Posters
6
Posts (Today)
0
Posts (Total)
15
Created
03/26/12
Type
Free
Moderators


Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing
to market innovative central nervous system therapies. Allon's lead drug davunetide is proceeding in a pivotal clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA). The trial is complete and on track to analyse the data and release top-line results before the end of 2012. This pivotal trial is based upon statistically significant human efficacy demonstrated in patients with amnestic mild cognitive impairment, cognitive impairment associated with schizophrenia, and in positive
biomarker data.

Board Info
Posts Today
0
Posts (Total)
15
Posters
6
Moderators
New Post